| Will psychedelics be ‘a revolution in psychiatry’?
https://www.nature.com/articles/d41573-021-00087-7 The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame) https://psyarxiv.com/u6v9y “Trial of Psilocybin versus Escitalopram for Depression“,
https://www.nejm.org/doi/full/10.1056/NEJMoa2032994 Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder. A Randomized Clinical Trial, Alan K. Davis et al., 2020
doi : 10.1001/jamapsychiatry.2020.3285 Can Psychedelic Drugs Attenuate Age-Related Changes in Cognition and Affect?
https://link.springer.com/article/10.1007/s41465-019-00151-6 LSD is one of the safest drugs there are. You may get a bad trip but it ends. Of course people in danger of psychosis should not take it. People don't get addicted to LSD or psychedelics in general. It's not something you want to take frequently (excluding some who microdose at the levels where you don't feel the psychedelics effects). |
How can one determine if they are at risk of psychosis prior to consuming LSD? I've heard many stories of people who were "never the same" (in a bad life-outcome sense) after having bad LSD trips. It wasn't clear from family history or medical history that they were at-risk for such a reaction.
At least based on these outcomes, it might be a bit inaccurate to claim LSD is safe. I suspect it was outlawed in part due to observed risks decades ago, but am still curious about political motivations. (e.g. "they want to deny us access to knowledge, man." or racial reasons, etc)
Perhaps there will be technology advancements in support of ascertaining propensity for adverse reactions to psychedelics. I suspect there's a strong component related to dosage. Maybe this is related to the microdosing movement?